Best Chemotherapy for testicular cancer Doctors in Turkey for Australians

Professor Mustafa Solak completed a specialist fellowship at the University of Texas MD Anderson Cancer Center – ranked as the top cancer hospital in the United States.

• Specialises in treating complex testicular and germ cell tumours
• Uses evidence-based protocols including targeted therapy and immunotherapy
• Fellowship trained at the Hacettepe University Cancer Institute
• Expert in managing systemic treatments for advanced solid tumours
• Former specialist at Hitit University Corum Training Hospital

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Professor Sezer Sağlam is a senior medical oncologist at Gayrettepe Florence Nightingale Hospital, specialising in complex systemic cancer treatments.

• Holds full professorship in oncology from Istanbul University
• Completed specialised fellowship training at the Istanbul Medical Faculty
• Active member of the American Society of Clinical Oncology (ASCO)
• Member of the European Society for Medical Oncology (ESMO)
• Specialised in gastrointestinal oncology and neuroendocrine tumours

Associate Professor Abdullah Sakin is the former Head of Medical Oncology at Yüzüncü Yıl University Faculty of Medicine and currently leads oncology services at Medipol Bahçelievler.

• Specialised in medical oncology at the Okmeydanı Training and Research Hospital
• Served as the Medical Oncology Clinic Education Officer at Prof Dr Cemil Taşçıoğlu City Hospital
• Directs treatment protocols for complex testicular cancer cases requiring systemic chemotherapy
• Board-certified in both internal medicine and medical oncology

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Dr. Yesim Yildirim is a medical oncologist at Anadolu Medical Center. She specializes in immunotherapy and targeted therapy for breast, lung, and gastrointestinal cancers. Dr. Yildirim is ESMO-certified and holds the rank of Professor. She completed training at Mount Vernon in the UK and Rambam Medical Center.

• Authored over 80 scientific publications on tumor biology and precision medicine.
• Treats complex cases including melanoma, sarcomas, and stage 4 lung cancer.
• Member of ASCO and the International Society of Gastrointestinal Oncology.
• Works at Anadolu Medical Center, an affiliate of Johns Hopkins Hospital.

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Professor Sezer Saglam is a senior medical oncologist at Istanbul Florence Nightingale Hospital with high-level expertise in systemic cancer therapies.

• Holds the rank of Professor in Medical Oncology – the highest academic medical distinction in Turkey
• Completed specialist fellowship training at the Istanbul University Oncology Institute
• Maintains international standards through active membership in ASCO and ESMO
• Specialises in managing complex chemotherapy protocols for testicular and solid tumours
• Collaborates with a multidisciplinary team at a JCI-accredited excellence centre

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Professor Cemil Bilir is a highly qualified medical oncologist at VM Medical Park Pendik who has reached the top academic rank in his field.

• Completed a research fellowship at Northeastern University in Boston specialising in pharmaceutical biotechnology
• Underwent specialised training rotations at the prestigious Cleveland Clinic in the United States
• Serves as a Professor of Medical Oncology at Sakarya University Faculty of Medicine
• Active member of the European Society for Medical Oncology and American Society of Clinical Oncology
• Pursuing a PhD in inorganic chemistry to enhance his knowledge of drug interactions

Associate Professor Muhammed Mustafa Atci is a clinical expert in non-seminomatous testicular cancer, focusing on advanced biomarkers to improve patient outcomes.

• Researches the De Ritis Ratio as a specific biomarker for lung metastasis in testicular cancer
• Serves as the Education Coordinator for the Medical Oncology Sub-Branch at a major city hospital
• Active member of the American Society of Clinical Oncology (ASCO) since 2018
• Maintains a high academic profile with extensive research published in the Journal of Chemotherapy
• Practises at the JCI-accredited İstinye University Liv Hospital Topkapı

Professor Ercan Ozden is a medical oncology specialist at VM Medical Park Pendik Hospital who completed a competitive English-language medical programme at Istanbul University.

• Specialised in medical oncology at Kocaeli University Faculty of Medicine
• Completed an internal medicine residency at the prestigious Cerrahpasa Faculty of Medicine
• Focuses on pharmacological protocols for solid tumours and oncology subspecialties
• Experienced in managing complex medication regimes for male reproductive cancers

Professor Irfan Cicin is a senior medical oncologist who leads complex cancer care at İstinye University Liv Hospital Topkapı. He holds the highest academic rank of Professor, reflecting his role in training the next generation of specialists.

• Completed specialist fellowship training in medical oncology at Trakya University
• Published extensive research on modern systemic therapy protocols
• Served as a specialist physician for the Turkish Air Force
• Member of the Turkish Society of Medical Oncology
• Focuses on pharmacological management of solid male reproductive tumours

Professor Mustafa Serkan Alemdar is a dual-certified specialist in internal medicine and medical oncology at Medical Park Antalya. He leads complex chemotherapy regimens with a focus on patient-specific treatment protocols.

• Specialised in medical oncology at Akdeniz University Faculty of Medicine
• Managed oncology cases at Antalya Training and Research Hospital
• Highly experienced in internal medicine and systemic cancer therapies
• Registered with the Turkish Medical Oncology Association

Associate Professor Atakan Topcu is an expert in medical oncology at Medipol Acibadem District Hospital, where he manages complex solid tumours. He focuses on integrating nutrition and supportive care into cancer treatment plans for better patient outcomes.

• Completed a clinical observership at the University of Leicester in the United Kingdom
• Published over 50 scientific articles on cancer prognosis and treatment response
• Specialises in immunotherapy and targeted agents for advanced solid tumours
• Member of the European Society for Medical Oncology (ESMO)
• Editorial Board Member for the peer-reviewed medical journal BMC Cancer

Associate Professor Ayse Irem Yasin is a highly credentialed medical oncologist who holds a European Society for Medical Oncology (ESMO) board certification.

• Specialises in urological cancers, providing targeted chemotherapy protocols for testicular cancer cases
• Completed international observerships at world-leading institutions including Cleveland Clinic and Harvard Medical School
• Serves as Associate Professor at Medipol Acibadem District Hospital, contributing to academic oncology research
• Previously trained at specialised breast and internal medicine units across Italy and Switzerland

Associate Professor Nail Paksoy is an ESMO board-certified medical oncologist specialising in advanced chemotherapy protocols at Medipol Bahcelievler University Hospital.

• Holds European Society for Medical Oncology (ESMO) board certification from Paris
• Published research on high-dose chemotherapy for sarcomas and rare solid tumours
• Active sub-investigator in international clinical trials for Roche, Pfizer, and Merck
• Expertise in managing complex chemotherapy toxicities and patient desensitisation protocols